The infant clinical nutrition market refers to the segment of the baby food industry that focuses on specialized nutrition for infants with specific health conditions. These conditions may include premature birth, low birth weight, digestive issues, and metabolic disorders. Infant clinical nutrition products are designed to provide essential nutrients in specific quantities and ratios to support healthy growth and development in these vulnerable infants.
The global infant clinical nutrition market has been growing in recent years due to the increasing prevalence of premature births and other health conditions that require specialized nutrition. According to a report by Grand View Research, the global infant clinical nutrition market was valued at $17.3 billion in 2020 and is expected to reach $30.1 billion by 2028, growing at a CAGR of 7.3% from 2021 to 2028.
Some of the key players in the infant clinical nutrition market include Nestlé S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Perrigo Company plc. These companies offer a range of infant clinical nutrition products, including preterm formulas, low birth weight formulas, amino acid-based formulas, hydrolyzed protein formulas, and other specialized formulas.
The Asia-Pacific region is expected to be the fastest-growing market for infant clinical nutrition, driven by factors such as increasing birth rates, improving healthcare infrastructure, and growing awareness of the importance of proper nutrition for infants with health conditions. North America and Europe are also significant markets for infant clinical nutrition, due to the high prevalence of premature births and other health conditions in these regions.
In addition to specialized formulas, some companies are also developing innovative nutritional supplements and other products to support infant health. For example, Nestlé Health Science recently launched a nutritional supplement called Alfamino® INFANT, which is designed to help infants with cow’s milk allergy, eosinophilic esophagitis, and other digestive issues.
Overall, the infant clinical nutrition market is expected to continue growing in the coming years, driven by the increasing prevalence of health conditions that require specialized nutrition and ongoing innovation in the development of new products to meet the unique needs of these vulnerable infants.